Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat

E-ISSN： 1873-5592|11|6|667-681

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.6, 2010-06, pp. : 667-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P53 Family: At the Crossroads in Cancer Therapy

Current Medicinal Chemistry, Vol. 16, Iss. 32, 2009-11 ,pp. : 4328-4344

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of the p53 pathway in cancer stem cells

By Prabhu Varun V Allen Joshua E Hong Bo Zhang Shengliang Cheng Hairong El-Deiry Wafik S

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 553-574

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3248-3262

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite